Immunological factors, but not clinical features, predict visceral leishmaniasis relapse in patients co-infected with HIV
Preprint
Abstract
Visceral leishmaniasis (VL) has emerged as a clinically important opportunistic infection in HIV patients, as VL/HIV co-infected patients suffer from frequent VL relapse. Here, we followed cohorts of VL patients with or without HIV co-infections in Ethiopia and collected detailed clinical and immunological data during 12 months of follow-up. By the end of the study 78.1% of VL/HIV patients, but none of the VL only patients, had relapsed. Despite clinically defined cure, VL/HIV patients maintained high parasite loads, low BMI, hepatosplenomegaly and pancytopenia throughout follow-up. During detailed immunological study throughout the follow-up period, we identified three markers associated with VL relapse: i) failure to restore antigen-specific production of IFNγ, ii) persistently low CD4 + T cell counts, and iii) high expression of PD1 on CD4 + T cells. We show that these three markers combine well in predicting VL relapse, and that all three measurements are needed for optimal predictive power. These three immunological markers can be measured in primary hospital settings in Ethiopia and can predict VL relapse after anti-leishmanial therapy. The use of our prediction model has the potential to improve disease management and patient care.Keywords
All Related Versions
- Published version: Cell Reports Medicine, 3 (1), 100487.
This publication has 51 references indexed in Scilit:
- Long term outcomes and prognostics of visceral leishmaniasis in HIV infected patients with use of pentamidine as secondary prophylaxis based on CD4 level: a prospective cohort study in EthiopiaPLOS Neglected Tropical Diseases, 2019
- Eco-epidemiology of visceral leishmaniasis in EthiopiaParasites & Vectors, 2015
- Visceral Leishmaniasis in Ethiopia: An Evolving DiseasePLOS Neglected Tropical Diseases, 2014
- High Parasitological Failure Rate of Visceral Leishmaniasis to Sodium Stibogluconate among HIV Co-infected Adults in EthiopiaPLOS Neglected Tropical Diseases, 2014
- Visceral LeishmaniasisInfectious Disease Clinics of North America, 2012
- Predictors of Visceral Leishmaniasis Relapse in HIV-Infected Patients: A Systematic ReviewPLOS Neglected Tropical Diseases, 2011
- Clinical characteristics and treatment outcome of patients with visceral leishmaniasis and HIV co‐infection in northwest EthiopiaTropical Medicine & International Health, 2010
- The pathogenesis ofLeishmania/HIV co-infection: cellular and immunological mechanismsPathogens and Global Health, 2003
- Visceral leishmaniasis in clinical practiceJournal of Infection, 1999
- Leishmania and human immunodeficiency virus coinfection: the first 10 yearsClinical Microbiology Reviews, 1997